Search research articles
Contact Us
Filters
Showing results (1-10 of 143) with videos related to
Page
of 15
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
March 19, 2019
What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?
Sara Bravaccini
Methods in Molecular Biology (Clifton, N.J.)
|
March 2, 2021
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit)
Sara Bravaccini
Methods in Molecular Biology (Clifton, N.J.)
|
March 2, 2021
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer
Valentina Casadio, Sara Bravaccini
Breast Cancer Research : BCR
|
April 5, 2019
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
Sara Bravaccini, Roberta Maltoni
Journal of Personalized Medicine
|
November 27, 2021
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
Sara Bravaccini, Roberta Maltoni
Annals of Translational Medicine
|
May 9, 2022
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer
Roberta Maltoni, Sara Bravaccini
Cancer Cytopathology
|
September 22, 2018
Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?
Sara Bravaccini, Giuseppe Bronte
Breast Cancer Research and Treatment
|
May 24, 2019
What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?
Roberta Maltoni, Sara Bravaccini
Translational Lung Cancer Research
|
March 25, 2020
What's the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors?
Sara Bravaccini, Paola Ulivi
Cell Transplantation
|
September 10, 2020
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?
Sara Bravaccini, Giovanni Martinelli, Claudio Cerchione
Page
of 15
Search research articles
Search
Showing results (1-10 of 143) with videos related to
Sort By:
Page
of 15
Lung Cancer (Amsterdam, Netherlands)
|
March 19, 2019
What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?
Sara Bravaccini
Methods in Molecular Biology (Clifton, N.J.)
|
March 2, 2021
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit)
Sara Bravaccini
Methods in Molecular Biology (Clifton, N.J.)
|
March 2, 2021
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer
Valentina Casadio, Sara Bravaccini
Breast Cancer Research : BCR
|
April 5, 2019
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
Sara Bravaccini, Roberta Maltoni
Journal of Personalized Medicine
|
November 27, 2021
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
Sara Bravaccini, Roberta Maltoni
Annals of Translational Medicine
|
May 9, 2022
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer
Roberta Maltoni, Sara Bravaccini
Cancer Cytopathology
|
September 22, 2018
Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?
Sara Bravaccini, Giuseppe Bronte
Breast Cancer Research and Treatment
|
May 24, 2019
What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?
Roberta Maltoni, Sara Bravaccini
Translational Lung Cancer Research
|
March 25, 2020
What's the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors?
Sara Bravaccini, Paola Ulivi
Cell Transplantation
|
September 10, 2020
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?
Sara Bravaccini, Giovanni Martinelli, Claudio Cerchione
Page
of 15